Evercode Whole Transcriptome News Today

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced a significant update to the companys flagship Evercode Whole Transcriptome products.

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with builtin Parse Evercode single cell protocols

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with India-based Spinco ...

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions announced today the launch of CRISPR Detect enabling single cell pooled CRISPR screens at unprecedented scale.

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced an agreement with Israelbased Ornat Biochemicals and Laboratory Equipment to extend Parses reach in the Middle East.

On Wednesday, 10X Genomics, Inc. filed a complaint in the District of Delaware against Parse Biosciences, Inc. and the Board of Trustees of Leland

Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall ...

Company to commercialize and create single-cell multi-omics products Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series